- Country: Peru
- Summary: ?Adquisicion De Medicamento Fuera De Petitorio Farmacologico Pembrolizumab 100Mg Para Pacientes Del Servicio De Oncologia Medica Del Hospital Guillermo Almenara Irigoyen ? Eshealth?
- PET Ref No: 132617160
- Deadline: 07 Jan 2026
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: DIRECTA-DIRECTA-38-2025-ESSALUD-RPA-1
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- ?ACQUISITION OF MEDICATION OUTSIDE OF PHARMACOLOGICAL REQUEST PEMBROLIZUMAB 100MG FOR PATIENTS OF THE MEDICAL ONCOLOGY SERVICE OF THE GUILLERMO ALMENARA IRIGOYEN HOSPITAL? ESHEALTH?
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGIN?Adquisicion De Medicamento Fuera De Petitorio Farmacologico Pembrolizumab 100Mg Para Pacientes Del Servicio De Oncologia Medica Del Hospital Guillermo Almenara Irigoyen ? Eshealth? - Peru Tender
The SOCIAL HEALTH INSURANCE, a Government sector organization in Peru, has announced a new tender for ?Adquisicion De Medicamento Fuera De Petitorio Farmacologico Pembrolizumab 100Mg Para Pacientes Del Servicio De Oncologia Medica Del Hospital Guillermo Almenara Irigoyen ? Eshealth?. This tender is published on PeruTenders under PET Ref No: 132617160 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2026-01-07.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
